5-137870288-GACACACACACACACACACACACAC-GACACACACACACACACACACACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_006790.3(MYOT):c.-211-115_-211-114dupCA variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.48 ( 15145 hom., cov: 0)
Consequence
MYOT
NM_006790.3 intron
NM_006790.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Publications
0 publications found
Genes affected
MYOT (HGNC:12399): (myotilin) This gene encodes a cystoskeletal protein which plays a significant role in the stability of thin filaments during muscle contraction. This protein binds F-actin, crosslinks actin filaments, and prevents latrunculin A-induced filament disassembly. Mutations in this gene have been associated with limb-girdle muscular dystrophy and myofibrillar myopathies. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 5-137870288-G-GAC is Benign according to our data. Variant chr5-137870288-G-GAC is described in ClinVar as Benign. ClinVar VariationId is 1261559.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.542 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006790.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYOT | TSL:1 MANE Select | c.-211-153_-211-152insAC | intron | N/A | ENSP00000239926.4 | A0A0C4DFM5 | |||
| MYOT | c.-211-153_-211-152insAC | intron | N/A | ENSP00000638701.1 | |||||
| MYOT | TSL:2 | c.-205-153_-205-152insAC | intron | N/A | ENSP00000426281.1 | B4DT68 |
Frequencies
GnomAD3 genomes AF: 0.482 AC: 61074AN: 126684Hom.: 15138 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
61074
AN:
126684
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.482 AC: 61095AN: 126756Hom.: 15145 Cov.: 0 AF XY: 0.482 AC XY: 28928AN XY: 60044 show subpopulations
GnomAD4 genome
AF:
AC:
61095
AN:
126756
Hom.:
Cov.:
0
AF XY:
AC XY:
28928
AN XY:
60044
show subpopulations
African (AFR)
AF:
AC:
10440
AN:
33226
American (AMR)
AF:
AC:
6277
AN:
12136
Ashkenazi Jewish (ASJ)
AF:
AC:
1893
AN:
3230
East Asian (EAS)
AF:
AC:
2338
AN:
4384
South Asian (SAS)
AF:
AC:
1635
AN:
3584
European-Finnish (FIN)
AF:
AC:
3791
AN:
6712
Middle Eastern (MID)
AF:
AC:
140
AN:
264
European-Non Finnish (NFE)
AF:
AC:
33201
AN:
60694
Other (OTH)
AF:
AC:
884
AN:
1716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1379
2758
4136
5515
6894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.